Over the last 7 days, the United States market has dropped 2.1%, yet it remains up 30% over the past year, with earnings forecast to grow by 15% annually. In this context, identifying high growth tech ...
Cadrenal aims to develop a better VKA blood thinner for these warfarin-dependent patients. Cadrenal Therapeutics, Inc. is a biopharmaceutical company focused on developing tecarfarin, a clinical-stage ...
Several lines of evidence both from experimental models and from clinical studies reveal that TNF-like ligand 1A (TL1A) and its interaction with death receptor 3 (DR3) is critically involved in ...
Anti-TNF drugs have revolutionized the treatment of rheumatoid arthritis (RA). Concerns about risks of infection and malignancy with these agents have led to scrutiny of available data. Patients ...